Notify me when Omega Fund Management, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 11 | $286,520,063 | +$3,160,500 | -$33,221,500 | -$30,061,000 | NUVB, BBOT, BBNX, BCAX, KMTS | 13F-HR | 17 Feb 2026, 09:00 |
| Q3 2025 | 12 | $222,365,157 | +$41,805,466 | -$38,750,539 | +$3,054,927 | KMTS, BBNX, BBOT, BCAX, NUVB | 13F-HR | 14 Nov 2025, 09:00 |
| Q2 2025 | 13 | $154,437,217 | $0 | -$6,444,743 | -$6,444,743 | BBNX, KMTS, UPB, NUVB, BCAX | 13F-HR | 14 Aug 2025, 08:28 |
| Q1 2025 | 13 | $169,462,464 | +$69,090,287 | -$57,792 | +$69,032,495 | KMTS, BCAX, BBNX, NUVB, REPL | 13F-HR | 15 May 2025, 08:18 |
| Q4 2024 | 1 | $33,476,657 | $0 | $0 | $0 | UPB | New Holdings | 15 May 2025, 08:16 |
| Q4 2024 | 12 | $154,184,254 | +$33,476,657 | -$17,251,309 | +$16,225,348 | BCAX, NUVB, UPB, REPL, LXEO | 13F-HR | 14 Feb 2025, 09:00 |
| Q3 2024 | 11 | $160,008,733 | +$56,152,436 | -$5,912,090 | +$50,240,346 | BCAX, NUVB, REPL, LXEO, ENGN | 13F-HR | 14 Nov 2024, 07:56 |
| Q2 2024 | 11 | $134,971,971 | +$8,687,893 | -$8,475,165 | +$212,728 | NUVB, LXEO, REPL, ENGN, ALMS | 13F-HR | 14 Aug 2024, 16:00 |
| Q1 2024 | 11 | $155,010,742 | +$3,109,046 | -$23,506,520 | -$20,397,474 | NUVB, LXEO, REPL, ENGN, SANA | 13F-HR | 14 May 2024, 16:01 |
| Q4 2023 | 14 | $123,436,831 | +$39,799,861 | -$1,759,865 | +$38,039,996 | LXEO, REPL, NUVB, ENGN, MORF | 13F-HR | 14 Feb 2024, 16:00 |
| Q3 2023 | 12 | $108,875,488 | $0 | -$21,478,826 | -$21,478,826 | REPL, NUVB, IKNA, MORF, KRON | 13F-HR | 14 Nov 2023, 09:00 |
| Q2 2023 | 12 | $178,485,676 | $0 | -$23,155,354 | -$23,155,354 | REPL, NUVB, ALPN, MORF, IKNA | 13F-HR | 14 Aug 2023, 09:01 |
| Q1 2023 | 14 | $153,322,996 | $0 | -$121,880,577 | -$121,880,577 | REPL, NUVB, MORF, ALPN, IKNA | 13F-HR | 15 May 2023, 16:00 |
| Q4 2022 | 16 | $296,715,662 | $0 | -$48,738,666 | -$48,738,666 | IMGO, REPL, NUVB, MORF, ALPN | 13F-HR | 13 Feb 2023, 16:50 |
| Q3 2022 | 19 | $273,064,000 | +$1,618,000 | -$49,669,030 | -$48,051,030 | REPL, IMGO, NUVB, CINC, GOSS | 13F-HR | 14 Nov 2022, 14:04 |
| Q2 2022 | 21 | $313,294,000 | +$386,000 | -$50,282,551 | -$49,896,551 | REPL, NUVB, IMGO, MORF, CINC | 13F-HR | 15 Aug 2022, 09:00 |
| Q1 2022 | 22 | $488,614,000 | +$16,947,000 | -$6,123,200 | +$10,823,800 | NUVB, REPL, IMGO, MORF, KRON | 13F-HR | 13 May 2022, 14:10 |
| Q4 2021 | 22 | $707,272,000 | +$9,022,000 | -$74,661,431 | -$65,639,431 | NUVB, REPL, IMGO, MORF, KRON | 13F-HR | 14 Feb 2022, 06:31 |
| Q3 2021 | 26 | $891,379,000 | +$108,854,291 | -$49,306,980 | +$59,547,311 | NUVB, REPL, KRON, MORF, IMGO | 13F-HR | 15 Nov 2021, 16:00 |
| Q2 2021 | 2 | $279,245,000 | $0 | $0 | $0 | NUVB, SANA | New Holdings | 15 Nov 2021, 16:47 |
| Q2 2021 | 23 | $883,596,000 | +$3,882,258 | -$31,972,373 | -$28,090,115 | NUVB, REPL, MORF, KRON, IKNA | 13F-HR | 16 Aug 2021, 07:53 |
| Q1 2021 | 2 | $323,059,000 | $0 | $0 | $0 | NUVB, SANA | New Holdings | 15 Nov 2021, 16:42 |
| Q1 2021 | 24 | $1,057,223,000 | +$393,791,304 | -$56,264,473 | +$337,526,831 | NUVB, REPL, MORF, KRON, IKNA | 13F-HR | 17 May 2021, 11:20 |
| Q4 2020 | 19 | $666,876,000 | +$218,935,000 | -$17,389,853 | +$201,545,147 | REPL, KRON, MORF, SPRB, AVIR | 13F-HR | 16 Feb 2021, 15:29 |
| Q3 2020 | 16 | $369,660,000 | +$34,458,972 | -$19,431,393 | +$15,027,579 | REPL, MORF, GOSS, IMUX, ARQT | 13F-HR | 16 Nov 2020, 08:17 |
| Q2 2020 | 15 | $365,744,000 | +$1,446,671 | -$39,193,487 | -$37,746,816 | REPL, MORF, GOSS, ARQT, IMUX | 13F-HR | 14 Aug 2020, 17:50 |
| Q1 2020 | 16 | $241,630,000 | +$31,533,698 | -$23,622,052 | +$7,911,646 | REPL, MORF, GOSS, ARQT, TBIO | 13F-HR | 14 May 2020, 09:53 |
| Q4 2019 | 14 | $314,167,000 | +$3,146,686 | -$6,779,831 | -$3,633,145 | GOSS, REPL, MORF, TBIO, IMUX | 13F-HR | 13 Feb 2020, 09:50 |
| Q3 2019 | 14 | $324,015,000 | +$2,368,977 | -$7,393,720 | -$5,024,743 | GOSS, REPL, MORF, TBIO, IMUX | 13F-HR | 13 Nov 2019, 09:15 |
| Q2 2019 | 15 | $392,079,000 | +$92,894,000 | -$9,884,736 | +$83,009,264 | GOSS, REPL, MORF, TBIO, IMUX | 13F-HR | 13 Aug 2019, 08:55 |
| Q1 2019 | 13 | $311,888,000 | $0 | $0 | $0 | GOSS, REPL, TBIO, PRTK, OBSVF | New Holdings | 17 May 2019, 19:26 |
| Q1 2019 | 13 | $311,888,000 | +$150,681,220 | -$15,952,000 | +$134,729,220 | GOSS, REPL, TBIO, PRTK, OBSVF | 13F-HR | 15 May 2019, 08:49 |
| Q4 2018 | 14 | $134,874,000 | +$15 | -$1,018,402 | -$1,018,387 | REPL, TBIO, KZR, PRTK, OBSVF | 13F-HR | 11 Feb 2019, 09:21 |
| Q3 2018 | 14 | $211,385,000 | +$85,422,000 | -$4,127,409 | +$81,294,591 | REPL, PRTK, TBIO, OBSVF, KZR | 13F-HR | 06 Nov 2018, 17:51 |
| Q2 2018 | 13 | $135,522,000 | +$42,830,000 | -$78,323,121 | -$35,493,121 | TBIO, PRTK, OBSVF, KZR, SNNAQ | 13F-HR | 02 Aug 2018, 11:47 |
| Q1 2018 | 11 | $17,612 | $0 | $0 | $0 | OBSVF, ESSA Pharma | 13F-HR | 04 May 2018, 10:03 |
| Q4 2017 | 12 | $138,312,000 | +$9,760,000 | -$25,648,070 | -$15,888,070 | PRTK, JUNO, SNNAQ, OBSVF, JNCE | 13F-HR | 05 Feb 2018, 10:57 |
| Q3 2017 | 11 | $176,759,000 | +$18,894,043 | -$36,673,010 | -$17,778,967 | PRTK, JUNO, FGEN, SNNAQ, JNCE | 13F-HR | 03 Nov 2017, 10:52 |
| Q2 2017 | 11 | $160,239,000 | +$11,937,000 | -$21,396,893 | -$9,459,893 | PRTK, JUNO, FGEN, Nabriva Therapeutics, JNCE | 13F-HR | 26 Jul 2017, 10:19 |
| Q1 2017 | 11 | $153,841,000 | +$12,747,000 | -$1,703,381 | +$11,043,619 | PRTK, JUNO, FGEN, EGLTQ, NBRV | 13F-HR | 09 May 2017, 10:12 |
| Q4 2016 | 11 | $123,236,000 | +$5,149,000 | -$2,545,210 | +$2,603,790 | PRTK, JUNO, EGLTQ, FGEN, NBRV | 13F-HR | 10 Feb 2017, 10:01 |
| Q3 2016 | 11 | $130,994,000 | $0 | -$1,872,251 | -$1,872,251 | JUNO, PRTK, EGLTQ, FGEN, NBRV | 13F-HR | 02 Nov 2016, 13:07 |
| Q2 2016 | 11 | $134,798,000 | +$6,792,060 | -$355,983 | +$6,436,077 | JUNO, PRTK, EGLTQ, FGEN, NBRV | 13F-HR | 03 Aug 2016, 12:21 |
| Q1 2016 | 11 | $144,173,000 | +$5,596,642 | -$59,248 | +$5,537,394 | JUNO, PRTK, EGLTQ, FGEN, NBRV | 13F-HR | 02 May 2016, 11:51 |
| Q4 2015 | 10 | $179,685,000 | +$1,866,487 | -$5,920,549 | -$4,054,062 | JUNO, PRTK, EGLTQ, FGEN, NBRV | 13F-HR | 10 Feb 2016, 14:16 |
| Q3 2015 | 10 | $177,613,000 | +$23,577,000 | $0 | +$23,577,000 | JUNO, PRTK, EGLTQ, FGEN, NBRV | 13F-HR | 04 Nov 2015, 16:17 |
| Q2 2015 | 7 | $0 | $0 | $0 | $0 | 13F-HR | 10 Aug 2015, 14:03 | |
| Q1 2015 | 7 | $0 | $0 | $0 | $0 | 13F-HR | 11 May 2015, 06:15 | |
| Q4 2014 | 7 | $0 | $0 | $0 | $0 | 13F-HR | 23 Mar 2015, 13:35 |